Supplementary Figure S2 from ctDNA for Prognostication and Monitoring in Patients with Metastatic Endometrial Carcinoma Treated with Olaparib: Validation in the GINECO-UTOLA Trial

Read full text Summarise with VIRAT
Authors: Guillaume Beinse, Valérie Taly, Alexandra F. Leary, Aurelia Baures, Isabelle Laure Ray-Coquard, Benoît You, Manuel Jorge Rodrigues, Laurence Gladieff, Sophie Abadie‐Lacourtoisie, Leïla Bengrine-Lefèvre, Pierre-Emmanuel Brachet, Coriolan Lebreton
+18 more Guillaume Meynard, P. Fournel, Jean‐Sébastien Frenel, Frédèric Selle, Rémy Largillier, Cyril Foa, Corina Cornila, Emilie Kaczmarek, Anne Claire Hardy Bessard, Véronique D’Hondt, Isabelle Cojean Zelek, Sophie Roche, Delphine Duliege, Marie‐Ange Mouret‐Reynier, Patrick Bouchaert, Pierre Laurent‐Puig, Florence Joly, Jérôme Alexandre
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Cancer Genomics and Diagnostics PARP inhibition in cancer therapy Endometrial and Cervical Cancer Treatments

Publication details

Publication date
1 April 2026
Language
EN